Tyra Biosciences logo

Tyra Biosciences Share Price Today

(NASDAQ: TYRA)

Tyra Biosciences share price is $11.1 & ₹965.36 as on 6 Mar 2025, 2.30 'hrs' IST

$11.1

0.15

(1.37%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Tyra Biosciences share price in Dollar and Rupees. Guide to invest in Tyra Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Tyra Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Tyra Biosciences share price movements

  • Today's Low: $10.82
    Today's High: $11.43

    Day's Volatility :5.32%

  • 52 Weeks Low: $10.76
    52 Weeks High: $29.60

    52 Weeks Volatility :63.67%

Tyra Biosciences (TYRA) Returns

PeriodTyra Biosciences IncIndex (Russel 2000)
3 Months
-27.82%
0.0%
6 Months
-48.1%
0.0%
1 Year
-44.47%
0.0%
3 Years
-0.09%
-11.6%

Tyra Biosciences (TYRA) Key Statistics

in dollars & INR

Previous Close
$10.95
Open
$10.99
Today's High
$11.4275
Today's Low
$10.82
Market Capitalization
$554.1M
Today's Volume
$194.1K
52 Week High
$29.6
52 Week Low
$10.755
Revenue TTM
$0.0
EBITDA
$-99.6M
Earnings Per Share (EPS)
$-1.61
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-28.66%

How to invest in Tyra Biosciences Stock (TYRA) from India?

It is very easy for Indian residents to invest directly in Tyra Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Tyra Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Tyra Biosciences or TYRA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Tyra Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Tyra Biosciences shares which would translate to 0.078 fractional shares of Tyra Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Tyra Biosciences, in just a few clicks!

Returns in Tyra Biosciences (TYRA) for Indian investors in Rupees

The Tyra Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Tyra Biosciences investment value today

Current value as on today

₹61,251

Returns

₹38,749

(-38.75%)

Returns from Tyra Biosciences Stock

₹43,712 (-43.71%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Tyra Biosciences (TYRA)

67%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Tyra Biosciences Stock from India on INDmoney has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Tyra Biosciences

  • RA Capital Management, LLC

    21.02%

  • Boxer Capital LLC

    12.74%

  • Canaan Partners XI LLC

    8.26%

  • Alta Partners Management Company, L.P.

    8.06%

  • Nextech Invest AG

    8.02%

  • Bvf Inc

    7.79%

Analyst Recommendation on Tyra Biosciences

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Tyra Biosciences(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Tyra Biosciences Stock (TYRA)

What analysts predicted

Upside of 175.42%

Target:

$30.57

Current:

$11.10

Insights on Tyra Biosciences Stock (Ticker Symbol: TYRA)

  • Price Movement

    In the last 6 months, TYRA stock has moved down by -48.1%
  • TYRA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 105.9%
  • TYRA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 44.1%

Tyra Biosciences Technicals Summary

Sell

Neutral

Buy

Tyra Biosciences is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Tyra Biosciences (TYRA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Tyra Biosciences Inc logo
-19.78%
-48.1%
-44.47%
-0.09%
-57.88%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Tyra Biosciences Inc logo
NA
NA
NA
-1.5
-0.29
-0.2
NA
6.85
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Tyra Biosciences Inc logo
Buy
$554.1M
-57.88%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Tyra Biosciences

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in Phase 1/2 clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in Phase 1 clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
Organization
Tyra Biosciences
Employees
49
CEO
Dr. Todd Harris Ph.D.
Industry
Miscellaneous

Management People of Tyra Biosciences

NameTitle
Dr. Todd Harris Ph.D.
Co-Founder, President, CEO, Secretary, Treasurer & Director
Mr. Daniel Bensen
Co-Founder & COO
Dr. Robert L. Hudkins Ph.D.
Chief Technology Officer
Dr. Ronald V. Swanson Ph.D.
Chief Scientific Officer
Mr. Ali D. Fawaz J.D.
General Counsel
Ms. Sarah Honig
Vice President of Corporate Development & Strategy
Liz Pagano
Senior Vice President of Human Resources
Dr. Piyush R. Patel Ph.D.
Chief Development Officer
Dr. Douglas Warner M.D.
Chief Medical Officer
Mr. Erik Goluboff
Senior Vice President of Clinical Development

Important FAQs about investing in TYRA Stock from India :

What is Tyra Biosciences share price today?

Tyra Biosciences share price today stands at $11.10, Open: $10.99 ; Previous Close: $10.95 ; High: $11.43 ; Low: $10.82 ; 52 Week High: $29.60 ; 52 Week Low: $10.76.

The stock opens at $10.99, after a previous close of $10.95. The stock reached a daily high of $11.43 and a low of $10.82, with a 52-week high of $29.60 and a 52-week low of $10.76.

Can Indians buy Tyra Biosciences shares?

Yes, Indians can invest in the Tyra Biosciences (TYRA) from India.

With INDmoney, you can buy Tyra Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Tyra Biosciences at zero transaction cost.

How can I buy Tyra Biosciences shares from India?

It is very easy to buy Tyra Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Tyra Biosciences (TYRA) be purchased?

Yes, you can buy fractional shares of Tyra Biosciences with INDmoney app.

What are the documents required to start investing in Tyra Biosciences stocks?

To start investing in Tyra Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Tyra Biosciences Stock (TYRA)?

Today’s highest price of Tyra Biosciences (TYRA) is $11.43.

Today’s lowest price of Tyra Biosciences (TYRA) is $10.82.

What is today's market capitalisation of Tyra Biosciences?

Today's market capitalisation of Tyra Biosciences TYRA is 554.1M

What is the 52 Week High and Low Range of Tyra Biosciences Stock (TYRA)?

  • 52 Week High

    $29.60

  • 52 Week Low

    $10.76

What are the historical returns of Tyra Biosciences (TYRA)?

  • 1 Month Returns

    -19.78%

  • 3 Months Returns

    -48.1%

  • 1 Year Returns

    -44.47%

  • 5 Years Returns

    -57.88%

Who is the Chief Executive Officer (CEO) of Tyra Biosciences ?

Dr. Todd Harris Ph.D. is the current Chief Executive Officer (CEO) of Tyra Biosciences.